SUBSCRIBE
SUBSCRIBE
News   Deals

Bristol-Myers Squibb Company Submits Letter to ImClone Systems Incorporated Board of Directors

September 11, 2008 | 
1 min read

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) submitted the following letter to ImClone Systems Incorporated (NASDAQ: IMCL) Board of Directors today:

Mergers & acquisitions
MORE ON THIS TOPIC
Puzzle Brain and US Currency. 3D rendering
Mergers & acquisitions
Lundbeck Deepens Neuro, Rare Disease Portfolio With $2.6B Longboard Buy
October 14, 2024
 · 
2 min read
 · 
Tristan Manalac
pharmacy medicine capsule pill in production line at medical factory
Deals
Amid Novo Buy, Catalent Offloads New Jersey Facility to Ardena
October 14, 2024
 · 
1 min read
 · 
Annalee Armstrong
Pictured: Entrance to the FTC's office in Washington, DC
Editorial
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
October 11, 2024
 · 
3 min read
 · 
Greg Slabodkin
Man inside a boat made with a dollar
M&A
Concentra Spies New Target After Kezar’s Lupus Trial Hold
October 9, 2024
 · 
1 min read
 · 
Kate Goodwin